Skip to main content Back to Top

Conversation with an Anesthesiologist: Key Issues on Neuromuscular Monitoring and Neuromuscular Blockade Reversal Strategies

Broadcast Date: March 15, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies.


J. Ross RenewJ. Ross Renew, MD, FASA, FASE, is currently an Assistant Professor of Anesthesiology and serves as the Vice Chair of Research for his department at the Mayo Clinic in Jacksonville, Florida. Dr. Renew completed his anesthesiology residency at Mayo Clinic in Jacksonville, Florida and his Adult Cardiothoracic Anesthesiology at Mayo Clinic in Rochester, Minnesota.

Dr. Renew is an active researcher and leads a team interested in neuromuscular blockade, neuromuscular blockade monitoring, and practical strategies to optimize neuromuscular blockade management. In addition to his research efforts, he serves as the Associate Residency Director and is passionate about educating the next generation of anesthesiologists on the best way to manage neuromuscular blockade.

Rachel WolfeRachel C. Wolfe, PharmD, MHA, BCCCP, is Clinical Pharmacy Specialist of Perioperative and Surgical Critical Care at Barnes-Jewish Hospital and Washington University Medical Center in St. Louis, Missouri. She is also Adjunct Clinical Instructor for the Barnes-Jewish Hospital Goldfarb School of Nursing and St. Louis College of Pharmacy. , Dr. Wolfe is responsible for the provision of clinical pharmacy services in the perioperative and periprocedural environment and for the coordination of clinical services provided by four operating room pharmacy satellites. She also serves as a preceptor for Doctor of Pharmacy students and pharmacy residents and is co-chair of the Enhanced Surgical Recovery Pharmacy & Documentation committee and the Analgesia subcommittee of the Pharmacy & Therapeutics committee.

Dr. Wolfe earned her Doctor of Pharmacy degree from St. Louis College of Pharmacy and Master of Health Administration degree from Webster University, also in St. Louis. She completed her residency training at University of Kentucky HealthCare, and she is board certified in critical care.

Dr. Wolfe is a member of the American College of Clinical Pharmacy, American Society of Enhanced Recovery, and Society of Critical Care Medicine. In 2011 she received Barnes-Jewish Hospital’s David A. Gee Meritorious Service Award and Team Award for Quality Improvement for Anesthesia Medication Management.


Relevant Financial Relationship Disclosures

The following persons in control of this activity’s content have relevant financial relationships:

Rachel C. Wolfe - Merck: advisor and speaker's bureau

J. Ross Renew - Merck: investigator for a research grant

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Provided by ASHP
Supported by an educational grant from Merck